Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease

NCT04097080 is registered in ClinicalTrials.gov with Nobilis Therapeutics Inc. as lead sponsor.

NCT NCT04097080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04097080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
Lead sponsor
Nobilis Therapeutics Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
December 15, 2019
Completion date
December 31, 2021
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease